Level up your trading with our powerful tools and real-time insights all in one place.
The current BLUE market cap is 78.75M. The company's latest EPS is USD -1.0898 and P/E is -0.37.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.89M | 12.39M | 7.83M | 18.57M | 16.1M |
| Operating Income | -85.3M | -84.73M | -82.67M | -78.69M | -88.39M |
| Net Income | -72.91M | -71.73M | -88.51M | -69.8M | -81.39M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 44.67M | 257.2M | 31.31M | 3.6M | 29.5M |
| Operating Income | -814.83M | -623.05M | -563.26M | -389.09M | -337.19M |
| Net Income | -789.61M | -618.7M | -819.38M | -266.58M | -211.91M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 663.39M | 613.61M | 619.16M | 631.48M | 545.19M |
| Total Liabilities | 374.37M | 391.07M | 424.62M | 500.44M | 492.21M |
| Total Equity | 289.02M | 222.54M | 194.54M | 131.05M | 52.98M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.73B | 1.78B | 593.8M | 554.9M | 619.16M |
| Total Liabilities | 442.43M | 426.2M | 219.52M | 358.56M | 424.62M |
| Total Equity | 1.28B | 1.36B | 374.28M | 196.34M | 194.54M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -159.36M | -221.21M | -235.05M | -74.68M | -140.93M |
| Investing | 89.08M | 151.16M | 154.95M | -655k | 966k |
| Financing | 130.01M | 129.97M | 196.25M | 64.65M | 58.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -564.38M | -470.35M | -635.64M | -352.95M | -235.05M |
| Investing | 507.81M | -84.35M | 562.56M | 250.45M | 154.95M |
| Financing | 21.19M | 546.72M | -93.95M | 54.25M | 196.25M |
| Market Cap | 78.75M |
| Price to Earnings Ratio | -0.37 |
| Price to Sales Ratio | 2.64 |
| Price to Cash Ratio | 0.35 |
| Price to Book Ratio | 0.4 |
| Dividend Yield | - |
| Shares Outstanding | 194.44M |
| Average Volume (1 week) | 7.91M |
| Average Volume (1 Month) | 6.52M |
| 52 Week Change | -89.59% |
| 52 Week High | 5.53 |
| 52 Week Low | 0.29 |
| Spread (Intraday) | 0.01 (2.3%) |
| Company Name | bluebird bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.bluebirdbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
